CDMO Business Drug Delivery System (DDS)
Contract development and manufacturing of DDS for injectables and liquid formulations.
Since we started contract manufacturing of highly potent DDS formulations including liposomes, micelles and lipid nanoparticles in 2004, we have manufactured more than 10 DDS products to date. The highly potent injectables manufacturing building (No. 2 Injectables Building) has a dedicated production area for DDS. We also acquired revolutionary technology for manufacturing DDS in 2019 through collaborations with universities. As well as utilizing this technology, we will strengthen our business in the development and manufacturing of DDS and pursue further improvements in technology and quality in order to stably supply DDS at lower prices worldwide.